LFB-190

N/A

Report date: 2025/01/17 15:10:50

NME

Base Information

Drug NameLFB-190

Drug Alias NameLFB-190LFB190

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors

TargetsBromodomain and extra terminal domain protein

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesLeapfrog Bio Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumoursNeoplasms

Inactive IndicationsN/A

ATC CodeN/A